Search
01/03/2023
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Pombo-Suarez, M, Seoane-Mato, D, Diaz-Gonzalez, F, Cea-Calvo, L, Sanchez-Alonso, F, Sanchez-Jareno, M, Jovani, V, Garcia-Magallon, B, Martinez-Gonzalez, O, Campos-Fernandez, C, Manero, J, Diaz-Torne, C, Bohorquez, C, Ros-Vilamajo, I, Perez-Vera, Y, Castrejon, I. Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis. Musculoskeletal Care. 2023; 21(1)DOI:10.1002/msc.1684. PMID:35996810. IF:(Q/D).
01/11/2022
Early differentiated CD28(+) CD27(+) T lymphocytes as a biomarker for short and long-term outcomes in older patients with pneumonia
Franco-Leyva T., Torres O.H., Saez Prieto M.E., Boera-Carnicero G., Santos Á., Clotet S., Albert-Jares D., El-Ebiary Y., Agustí-Martí M., Casademont J., Juárez C., Martínez-Martínez L.. Early differentiated CD28(+) CD27(+) T lymphocytes as a biomarker for short and long-term outcomes in older patients with pneumonia. JOURNAL OF LEUKOCYTE BIOLOGY. 2022; 112(5)DOI:10.1002/JLB.5MA0422-370R. PMID:35748037. IF:5.500(Q2/3D).
01/09/2022
Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children
Galindo Zavala R., Bou-Torrent R., Mir-Perelló C., Martínez Regueira S., Magallares-López B., López-Corbeto M.. Effectiveness and safety of bisphosphonates therapy in secondary osteoporosis in children. ANALES DE PEDIATRIA. 2022; 97(3)DOI:10.1016/j.anpedi.2021.09.008. PMID:35915035. IF:2.100(Q3/6D).
01/09/2022
Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis
Sainz, L, Riera, P, Moya, P, Bernal, S, Casademont, J, Diaz-Torne, C, Millan, AM, Park, HS, Lasa, A, Corominas, H. Role of IL6R Genetic Variants in Predicting Response to Tocilizumab in Patients with Rheumatoid Arthritis. Pharmaceutics. 2022; 14(9)DOI:10.3390/pharmaceutics14091942. PMID:36145690. IF:5.400(Q1/2D).